Page 832 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

810 PART IV Specific Malignancies in the Small Animal Patient

541. Fant P, Caldin M, Furlanello T, et al.: Primary gastric histiocytic 564. Mason SL, Finotello R, Blackwood L: Epirubicin in the treatment
sarcoma in a dog—a case report, J Vet Med 51:358–362, 2004. of canine histiocytic sarcoma: sequential, alternating and rescue
542. Skorupski K, Clifford C, Paoloni M, et al.: CCNU for the treatment chemotherapy, Vet Comp Oncol 16:E30–E37, 2018.
VetBooks.ir 543. Naranjo C, Dubielzig R, Friedrichs K: Canine ocular histiocytic 565. Vail DM, Kravis LD, Cooley AJ, et al.: Preclinical trial of doxoru-
of dogs with histiocytic sarcoma, J Vet Int Med 21:121–126, 2007.
bicin entrapped in sterically stabilized liposomes in dogs with spon-
sarcoma, Vet Ophthalmol 10:179–185, 2007.
544. Vernau KM, Higgins RJ, Bollen AW, et al.: Primary canine and taneously arising malignant tumors, Cancer Chemother Pharmacol
39:410–416, 1997.
feline nervous system tumors: intraoperative diagnosis using the 566. Poirier VJ, Hershey AE, Burgess KE, et al.: Efficacy and toxicity of
smear technique, Vet Pathol 38:47–57, 2001. paclitaxel (Taxol) for the treatment of canine malignant tumors,
545. Snyder J, Lipitz L, Skorupski K, et al.: Secondary intracranial neo- J Vet Intern Med 18:219–222, 2004.
plasia in the dog: 177 cases (1986-2003), J Vet Intern Med 22:172– 567. Uno Y, Momio Y, Watari T, et al.: Malignant histiocytosis with
177, 2008. multiple skin lesions in a dog, J Vet Med Sci 55:1059–1061, 1993.
546. Mariani CL, Jennings MK, Olby NJ, et al.: Histiocytic sarcoma 568. Tripp CD, Fidel J, Anderson CL, et al.: Tolerability of metronomic
with central nervous system involvement in dogs: 19 Cases (2006– administration of lomustine in dogs with cancer, J Vet Intern Med
2012), J Vet Intern Med 29:607–613, 2015. 25:278–284, 2011.
547. Brown DE, Thrall MA, Getzy DM, et al.: Cytology of canine 569. Leach TN, Childress MO, Greene SN, et al.: Prospective trial of
malignant histiocytosis, Vet Clin Pathol 23:118–123, 1994. metronomic chlorambucil chemotherapy in dogs with naturally
548. Kato Y, Funato R, Hirata A, et al.: Immunocytochemical detection occurring cancer, Vet Comp Oncol 10:102–112, 2011.
of the class A macrophage scavenger receptor CD204 using air- 570. Hafeman S, London C, Elmslie R, et al.: Evaluation of liposomal
dried cytologic smears of canine histiocytic sarcoma, Vet Clin Pathol clodronate for treatment of malignant histiocytosis in dogs, Cancer
43:589–593, 2014. Immunol Immunother 59:441–452, 2010.
549. Pierezan F, Mansell J, Ambrus A, et al.: Immunohistochemical 571. Fidel J, Schiller I, Hauser Y, et al.: Histiocytic sarcomas in flat-
expression of ionized calcium binding adapter molecule 1 in cuta- coated retrievers: a summary of 37 cases (November 1998-March
neous histiocytic proliferative, neoplastic, and inflammatory disor- 2005), Vet Comp Oncol 4:63–74, 2006.
ders of dogs and cats, J Comp Pathol 151:347–351, 2014. 572. Friedrichs K, Young K: Histiocytic sarcoma of macrophage origin
550. The CADETSM HM assay. 2018. Retrieved from: https://www.sen- in a cat: case report with a literature review of feline histiocytic
tinelbiomedical.com/cadet-hm-for-vets/ malignancies and comparison with canine hemophagocytic histio-
551. Weiss DJ, Evanson OA, Sykes J: A retrospective study of canine cytic sarcoma, Vet Clin Pathol 37:121–128, 2008.
pancytopenia, Vet Clin Pathol 28:83–88, 1999. 573. Walton RM, Brown DE, Burkhard MJ, et al.: Malignant histiocy-
552. Newlands CE, Houston DM, Vasconcelos DY: Hyperferritinemia tosis in a domestic cat: cytomorphologic and immunohistochemi-
associated with malignant histiocytosis in a dog, J Am Vet Med Assoc cal features, Vet Clin Pathol 26:56–60, 1997.
205:849–851, 1994. 574. Kraje AC, Patton CS, Edwards DF: Malignant histiocytosis in 3
553. Friedrichs K, Thomas C, Plier M, et al.: Evaluation of serum fer- cats, J Vet Intern Med 15:252–256, 2001.
ritin as a tumor marker for canine histiocytic sarcoma, J Vet Intern 575. Smoliga J, Schatzberg S, Peters J, et al.: Myelopathy caused by a
Med 24:904–911, 2010. histiocytic sarcoma in a cat, J Small Anim Pract 46:34–38, 2005.
554. Nielsen LN, McEvoy F, Jessen LR, et al.: Investigation of a screen- 576. Bell R, Philbey A, Martineau H, et al.: Dynamic tracheal collapse
ing programme and the possible identification of biomarkers for associated with disseminated histiocytic sarcoma in a cat, J Small
early disseminated histiocytic sarcoma in Bernese mountain dogs, Anim Pract 47: 461-464, 2006.
Vet Comp Oncol 10:124–134, 2012. 577. Court E, Earnest-Koons K, Barr S, et al.: Malignant histiocytosis in
555. Tsai S, Sutherland-Smith, Burgess K, et al.: Imaging characteristics a cat, J Am Vet Med Assoc 203:1300–1302, 1993.
of intrathoracic histiocytic sarcoma in dogs, Vet Radiol Ultrasound 578. Ide T, Uchida K, Tamura S, et al.: Histiocytic sarcoma in the brain
53:21–27, 2012. of a cat, J Vet Med Sci 72:99–102, 2010.
556. Barrett LE, Pollard RE, Zwingenberger A, et al.: Radiographic 579. Ide K, Setoguchi-Mukai A, Nakagawa T, et al.: Disseminated his-
characterization of primary lung tumors in 74 dogs, Vet Radiol tiocytic sarcoma with excessive hemophagocytosis in a cat, J Vet
Ultrasound 55:480–487, 2014. Med Sci 71:817–820, 2009.
557. Cruz-Arambulo R, Wrigley R, Powers B: Sonographic features of 580. Pinard J, Wagg C, Girard C, et al.: Histiocytic sarcoma in the tarsus
histiocytic neoplasms in the canine abdomen, Vet Radiol Ultrasound of a cat, Vet Pathol 43:1014–1017, 2006.
45:554–558, 2004. 581. Treggiari E, Ressel L, Polton GA, et al.: Clinical outcome, PDG-
558. Weiss DJ: Flow cytometric evaluation of hemophagocytic disorders FRB and KIT expression in feline histiocytic disorders: a multicen-
in canine, Vet Clin Pathol 31:36–41, 2001. tre study, Vet Comp Oncol 15:65–77, 2017.
559. Klahn SL, Kitchell B, Dervisis N: Evaluation and comparison of 582. Affolter V, Moore P: Feline progressive histiocytosis, Vet Pathol
outcomes in dogs with periarticular and nonperiarticular histio- 43:646–655, 2006.
cytic sarcoma, J Am Vet Met Assoc 239:90–96, 2001. 583. Busch M, Reilly C, Luff J, et al.: Feline pulmonary Langerhans cell
560. Skorupski K, Rodriguez C, Krick E, et al.: Long-term survival in histiocytosis with multiorgan involvement, Vet Pathol 45:816–824,
dogs with localized histiocytic sarcoma treated with CCNU as an 2008.
adjuvant to local therapy, Vet Comp Oncol 7:139–144, 2009. 584. Jaffe ES: Histiocytic and dendritic cell neoplasms. In Jaffe ES, Har-
561. Rassnick K, Moore A, Russell D, et al.: Phase II, open-label trial of ris HL, Stein H, et al.: World Health Organization classification of
single-agent CCNU in dogs with previously untreated histiocytic tumors: pathology and genetics of tumors of haematopoietic and lym-
sarcoma, J Vet Intern Med 24:1528–1531, 2010. phoid tissues, 2001, pp 275–288.
562. Cannon C, Borgatti A, Henson M, et al.: Evaluation of a combina- 585. Shimono J, Miyoshi H, Arakawa F, et al.: Prognostic factors for his-
tion chemotherapy protocol including lomustine and doxorubicin tiocytic and dendritic cell neoplasms, Oncotarget 19:98723–98732,
in canine histiocytic sarcoma, J Sm Anim Pract 56:425–429, 2015. 2017.
563. Kezer KA, Barber LG, Jennings SH: Efficacy of dacarbazine as 586. Ozkaya N, Dogan A, Abdel-Wahab O: Identification and targeting
a rescue agent for histiocytic sarcoma in dogs, Vet Comp Oncol of kinase alterations in histiocytic neoplasms, Hematol Oncol Clin
16:77–80, 2018. North Am 31:705–719, 2017.